The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics.
Melvin KilsdonkCarlijn VeldmanStefano RosatiWouter PlattelArjan DiepstraPublished in: Histopathology (2022)
TARC immunohistochemistry has great value in differentiating between cHL and its mimics, including nodular lymphocyte-predominant Hodgkin lymphoma, reactive lymphadenopathies and mature lymphoid neoplasms with HRS-like cells.